Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms

Phase 3 Completed 272 enrolled Health Ever Bio-Tech Co., Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The hypothesis of the study is to examine whether MCS-2 is safe and effective in the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Timeline

Start: 2010-05
Primary completion: 2014-06
Completion: 2014-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	MCS-2	Unknown	30 mg	—

Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms

Summary

Timeline

Drugs

Indications